REGENXBIO, Inc. (RGNX)
8.79
+0.22
(+2.57%)
USD |
NASDAQ |
Mar 16, 16:00
8.80
+0.01
(+0.11%)
Pre-Market: 08:16
REGENXBIO Market Cap : 453.68M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.749B |
| AbbVie, Inc. | 391.56B |
| Replimune Group, Inc. | 607.73M |
| BioMarin Pharmaceutical, Inc. | 11.05B |
| Altimmune, Inc. | 453.34M |
Market Cap Related Metrics
| PS Ratio | 2.661 |
| Price to Book Value | 4.416 |
| Price | 8.79 |
| Earnings Yield | -42.71% |